Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged patents · clear
You spent months perfecting your invention. Weeks writing the application. But the rejection letter arrived anyway. The culprit? Often, it's something surprisingly simple: your drawings. After reviewing thousands of patent applications, I've…
Written by : Eric L. Abada For the past decade, controversy regarding the laws of patent eligibility has created uncertainty in the minds of inventors and investors, especially in the biotechnology, medical diagnostics, and software industries adjacent to…
Behind every patent litigation case is a skilled attorney preparing strategy, mastering complex IP law, and advocating for their client’s interests. These individuals play a key role in defining the outcome of disputes that often involve millions of…
Written by : Eric Wittgrove Medical device companies are often well versed in prosecuting multiple patents within a single “family.” Indeed, such families are often of significant value to early stage (and later stage) medical device companies.…
In an effort to fortify the European patent system and expedite the resolution of patent disputes, the European Patent Office (EPO) has introduced accelerated opposition proceedings. These measures, announced in response to parallel infringement or…
The United States Patent and Trademark Office (USPTO) has made an important announcement regarding the role of artificial intelligence (AI) in the patent process. With AI's growing influence in innovation and scientific research, questions have emerged…
A recent ruling by a court in Germany has sent shockwaves through the technology industry, as it has ordered an injunction against the sale of certain Intel chips. This decision comes after a legal battle between Intel and a US-based rival company, R2…
In a significant development for the global telecommunications industry, Nokia and OPPO have announced a multi-year patent cross-license agreement, marking the end of a prolonged legal dispute over 5G patent infringements. This resolution not only settles…
Written by : Rory R. Lootsma (December 27, 2023) Natera Inc. succeeded in obtaining a preliminary injunction against NeoGenomics Laboratories, Inc.’s medical assay test. Natera’s ongoing federal lawsuit alleges that NeoGenomics’ product…
On December 20, 2023, the UK Supreme Court made a significant ruling , stating that artificial intelligence (AI) systems are not eligible to be recognized as inventors in patent applications. This decision aligns with similar judgments from entities like…
Corcept Therapeutics experienced a significant drop in its stock value by 27% on Tuesday following an unfavorable verdict in a patent infringement lawsuit against Teva Pharmaceutical Industries (NASDAQ:TEVA). The ruling by a US District Court stated that…
In the intricate world of pharmaceuticals, where innovation meets regulation, ANDA litigation stands as a pivotal battleground. Abbreviated New Drug Application (ANDA) litigation plays a crucial role in determining the fate of generic drugs in the market.…
